FDA Drug Application (201635) for TROKENDI XR by SUPERNUS PHARMS

Back to FDA Applications sponsored by SUPERNUS PHARMS

Application Number201635
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTROKENDI XR
Active IngredientTOPIRAMATE

Active IngredientCount
List of drugs with Active Ingredient TOPIRAMATE6


Back to FDA Applications sponsored by SUPERNUS PHARMS